
European Investment Bank
Description
The European Investment Bank (EIB) serves as the long-term lending institution of the European Union, wholly owned by its 27 Member States. Established in 1958, its core mission is to finance sound and sustainable investment projects that contribute to the achievement of EU policy objectives. The EIB operates on a non-profit basis, borrowing funds on capital markets and lending them on favorable terms to support projects across various sectors, including infrastructure, innovation, climate action, and small and medium-sized enterprises (SMEs).
The EIB's financing mechanisms primarily involve direct loans for large-scale projects and intermediated loans for smaller initiatives, often channeled through partner banks and financial institutions. While direct loans typically target projects with a minimum investment cost, the EIB plays a crucial role in fostering economic growth, employment, and regional cohesion throughout the EU and in partner countries worldwide. Its strategic focus areas reflect the EU's priorities, with a significant emphasis on green transition and digital transformation.
In 2023, the EIB Group signed new financing of approximately €88 billion (around $95 billion), demonstrating its substantial financial capacity and commitment to investment. A considerable portion of this funding, specifically €21 billion (around $22.7 billion), was dedicated to supporting SMEs and mid-caps, highlighting the bank's role in bolstering the backbone of the European economy. The EIB's operations extend beyond lending, encompassing advisory services and technical assistance to ensure the effective implementation of projects and maximize their developmental impact.
Investor Profile
European Investment Bank has backed more than 426 startups, with 88 new investments in the last 12 months alone. The firm has led 353 rounds, about 83% of its total and boasts 105 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Debt Financing, Post Ipo Debt, Series Unknown rounds (top funding stages).
- Majority of deals are located in France, Germany, Spain.
- Strong thematic focus on Biotechnology, Energy, Health Care.
- Led 78 rounds in the past year.
- Typical check size: $27M – $1080M.
Stage Focus
- Debt Financing (62%)
- Post Ipo Debt (25%)
- Series Unknown (5%)
- Series B (2%)
- Grant (1%)
- Private Equity (1%)
- Series A (1%)
- Series C (1%)
- Series D (1%)
- Post Ipo Equity (1%)
Country Focus
- France (13%)
- Germany (12%)
- Spain (8%)
- Italy (7%)
- The Netherlands (6%)
- United States (6%)
- Finland (6%)
- Sweden (6%)
- Ireland (5%)
- Denmark (3%)
Industry Focus
- Biotechnology
- Energy
- Health Care
- Manufacturing
- Renewable Energy
- Medical
- Financial Services
- Software
- Information Technology
- Pharmaceutical
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.